Conjunctival squamous cell carcinoma

Summary

Conjunctival squamous cell carcinoma (MONDO:0006173) is a cancer and 2 clinical trials. A subtype of eye carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	conjunctival squamous cell carcinoma
Mondo ID	MONDO:0006173
EFO	EFO:1000206
DOID	DOID:1748
NCIT	C4549
SNOMED CT	255003007
UMLS	C0346359
MedGen	87558
GARD	0024318
Anatomy (UBERON)	UBERON:0001811
Is cancer (heuristic)	yes

Also known as: conjunctiva epidermoid carcinoma · conjunctiva squamous cell carcinoma · conjunctival epidermoid carcinoma · conjunctival squamous cell cancer · conjunctival squamous cell carcinoma · epidermoid carcinoma of conjunctiva · epidermoid carcinoma of the conjunctiva · ocular surface squamous neoplasia · squamous cell carcinoma of conjunctiva · squamous cell carcinoma of the conjunctiva

Data availability: 1 cell line.

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › head and neck carcinoma › eye carcinoma › conjunctival squamous cell carcinoma

Related subtypes (8): cornea squamous cell carcinoma, lacrimal gland carcinoma, eyelid carcinoma, eye carcinoma in situ, ocular sebaceous carcinoma, aniridia 2, aniridia 3, PAX6-related ocular dysgenesis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04704648	Not specified	RECRUITING	Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa
NCT05797415	Not specified	RECRUITING	Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers